Trials / Recruiting
RecruitingNCT06951984
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
Hydroxyephedrine PET/CT in Sympathetic Nervous System Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Tianjin Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Detailed description
Subjects with various sympathetic nerves-related disease patients underwent 11C/18F-HED PET/CT either for an initial assessment or for recurrence detection. Lesions uptake was quantified by the maximum standard uptake value (SUVmax). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 11C/18F-HED PET/CT were calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 11C/18F-HED | Each subject receive a single intravenous injection of 11C/18F-HED and undergo PET/CT or MRI imaging within the specificed time. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06951984. Inclusion in this directory is not an endorsement.